Reflux inhibitor drugs: an emerging novel therapy for gastroesophageal reflux disease.
Dent
John
J
Department of Gastroenterology and Hepatology, Royal Adelaide Hospital and University of Adelaide, North Terrace, Adelaide, South Australia, Australia. john.dent@health.sa.gov.au
D004358:Drug Therapy / Q000639:trends*; D018755:GABA Agonists / Q000494:pharmacology / Q000627:therapeutic use; D005764:Gastroesophageal Reflux / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control*; D006801:Humans; D009126:Muscle Relaxation / Q000187:drug effects; D064529:Receptor, Metabotropic Glutamate 5; D018094:Receptors, Metabotropic Glutamate / Q000037:antagonists & inhibitors
D018755:GABA Agonists; D064529:Receptor, Metabotropic Glutamate 5; D018094:Receptors, Metabotropic Glutamate